ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?

Gerald F. Watts, C Stefanutti

Research output: Contribution to journal › Letter

12 Citations (Scopus)

Original language	English
Pages (from-to)	3596-3599
Number of pages	4
Journal	European Heart Journal
Volume	37
Issue number	48
DOIs	https://doi.org/10.1093/eurheartj/ehw497
Publication status	Published - 21 Dec 2016

Access to Document

10.1093/eurheartj/ehw497

Cite this

@article{93c30ae6466f4f698006b20ad4ffd7d8,

title = "ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?",

author = "Watts, {Gerald F.} and C Stefanutti",

year = "2016",

month = dec,

day = "21",

doi = "10.1093/eurheartj/ehw497",

language = "English",

volume = "37",

pages = "3596--3599",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "48",

}

TY - JOUR

T1 - ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?

AU - Watts, Gerald F.

AU - Stefanutti, C

PY - 2016/12/21

Y1 - 2016/12/21

U2 - 10.1093/eurheartj/ehw497

DO - 10.1093/eurheartj/ehw497

M3 - Letter

C2 - 28087751

SN - 0195-668X

VL - 37

SP - 3596

EP - 3599

JO - European Heart Journal

JF - European Heart Journal

IS - 48

ER -